Comments
Commented by Stefan Feulner on May 27th, 2025 | 07:05 CEST
Bayer, Desert Gold, Snowflake – Breakout imminent
US President Donald Trump's tariff hammer against the European Union caused stock markets to falter at the close of the trading week, but the postponement of the measures by four weeks eased tensions over the weekend. As a result, Germany's leading index, the DAX, got off to a flying start to the week, regaining the 24,000-point mark. However, uncertainties remain, meaning the safe haven gold could once again rise to new highs.
Read
Commented by Nico Popp on May 27th, 2025 | 07:00 CEST
This commodity rule no longer applies: Barrick Gold, BHP Group, Globex Mining
The mining industry is undergoing change: ESG criteria are playing an increasingly important role. Megatrends such as the electrification of mobility and industry are changing global demand for commodities. At the same time, security of supply is becoming more critical due to increasing geopolitical tensions. Today, we take a look at three companies – Barrick Gold, BHP Group and Globex Mining – and explain why investors need to rethink their approach to commodity stocks, as old principles no longer apply in today's market.
Read
Commented by Stefan Feulner on May 26th, 2025 | 07:10 CEST
Cameco, Energy Fuels, Almonty Industries, Vonovia – Trump decision causes stocks to explode
US President Donald Trump is again flexing his muscles and sent stock markets worldwide into a tailspin at the end of the week. This time, his chosen target is not China or Russia, but instead Europe, which the Republican is hitting with his tariff hammer and threatening with import tariffs of 50%. Another plan to be implemented in the United States in the short term by decree is the acceleration of reactor approvals, which has led to double-digit gains for uranium stocks. The aim is to minimize dependence on energy imports.
Read
Commented by André Will-Laudien on May 26th, 2025 | 07:05 CEST
Tariffs, nuclear energy, and climate policy! Trump sets the pace for Nel ASA, First Hydrogen, Plug Power, and Oklo
The world is undergoing a 180-degree turn. Nuclear energy, which was demonized until 2022, is now experiencing an astonishing renaissance, and green seems to be redefined. Under Donald Trump, the US aims to expand the use of nuclear energy significantly, and the US president signed all the necessary decrees last week. Trump said that the United States intends to become "a real power" in the nuclear industry again by quadrupling its nuclear power production after his tour of the Middle East. Oil prices thus approached the critical USD 60 mark again, and hydrogen stocks experienced another sell-off. However, one problem is becoming apparent: 30-year bonds are now yielding over 5%. Stock market traders are now focusing on nuclear business models and uranium stocks. Where are the opportunities and risks?
Read
Commented by Fabian Lorenz on May 26th, 2025 | 07:00 CEST
RENK, D-Wave, and drone insider tip Volatus Aerospace: INSIDER SALE, SHARE PRICE EXPLOSION, 100% OPPORTUNITY
Another drone insider tip is Volatus Aerospace. There is growth potential in civil and military applications. The Company earns money, among other things, by training drone pilots and monitoring areas and bridges. Analysts expect strong sales and profit growth in the coming years and conservatively estimate that the stock could rise by more than 100%. Is it time to take profits at RENK? In any case, one insider has cashed in. This is understandable, given that the defense stock has already gained around 270% this year alone. And the quantum hype is back. Following a "milestone for the industry," D-Wave shares exploded by 50% in one week.
Read
Commented by Nico Popp on May 23rd, 2025 | 07:00 CEST
The low-cost electric vehicle is here! Opportunities at BYD, Albemarle Corporation, and European Lithium
The Dolphin Surf is set to be a game-changer for BYD. For the first time, a compact electric vehicle costs less than EUR 20,000. It features modern technology without compromise. The Chinese electric vehicle manufacturer is striking a chord with buyers who have long wished for an affordable electric vehicle for city driving. We explain what this means for the European electric vehicle market and where investors can seize opportunities now.
Read
Commented by André Will-Laudien on May 22nd, 2025 | 07:20 CEST
Caution! Takeover imminent at Evotec or BioNxt, tension remains high at Bayer and Valneva
In advanced stock market cycles, many investors wonder where returns can still be made. Defense and high tech have raced ahead, and a sector rotation remains, particularly in favor of biotech. Despite substantial gains in major indices such as the DAX 40, up nearly 20%, the Nasdaq Biotech Index (NBI) is still down nearly 7%. The excitement is mounting, as some stocks are heading north and delivering better-than-expected figures. From an analytical perspective, Evotec and BioNxt are so undervalued that a takeover can no longer be ruled out. Bayer has issued a strong statement to the US courts, and Valneva is set to outperform its previous year's Q1 figures significantly. Time for an update: Where are the buying opportunities?
Read
Commented by Nico Popp on May 22nd, 2025 | 07:15 CEST
Hydrogen: Solutions instead of pipe dreams – Ballard Power, Plug Power, dynaCERT
Do you remember the market five years ago? Stock prices knew no limits. Hydrogen companies in particular were considered the next big thing. And today? The era for grand visions is over. When it comes to hydrogen, what is needed now are tangible solutions that work immediately and pay off quickly. We take a closer look at the business models of Ballard Power, Plug Power, and dynaCERT - and we do not shy away from evaluating the stocks either. Which hydrogen stock is delivering returns right now?
Read
Commented by Armin Schulz on May 22nd, 2025 | 07:10 CEST
Overlooked gems? Why artificial intelligence will catapult Novo Nordisk, NetraMark, and UnitedHealth to the forefront
The pharmaceutical industry is undergoing a historic transformation. Artificial intelligence is compressing drug development times from decades to months, reducing costs by billions, and unlocking therapies for previously untreatable diseases. Algorithms sift through genome data, simulate drug candidates, and optimize clinical trials with a precision that surpasses that of human researchers. This disruption is not only creating medical milestones but also lucrative opportunities for investors. Today, we look at three candidates and analyze the current situation at Novo Nordisk, NetraMark Holdings, and UnitedHealth.
Read
Commented by Nico Popp on May 22nd, 2025 | 07:05 CEST
Three megatrends, one stock: Volatus Aerospace – Making millions with drones
Drones are transforming entire industries and are being used in more and more sectors. According to the Global Drone Industry Review market study, the number of commercial flight hours logged by drones rose by 42% to 10.8 million in 2024. Asia remains the region with the most drone flights. North America and Europe have some catching up to do. Canadian drone company Volatus Aerospace operates in several growth sectors and offers investors the opportunity to participate in the development of the commercial drone market with just one investment.
Read